Page last updated: 2024-08-26

tretazicar and Necrosis

tretazicar has been researched along with Necrosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bangma, CH; Irvine, AS; Kraaij, R; Lipinski, KS; Mills, KH; Mountain, A; Pelech, S; Todryk, SM1
Dexter, MT; Djeha, AH; Hulme, A; Kerr, DJ; Mountain, A; Searle, PF; Wrighton, CJ; Young, LS1

Other Studies

2 other study(ies) available for tretazicar and Necrosis

ArticleYear
Nitroreductase-based therapy of prostate cancer, enhanced by raising expression of heat shock protein 70, acts through increased anti-tumour immunity.
    Cancer immunology, immunotherapy : CII, 2006, Volume: 55, Issue:3

    Topics: Adenoviridae; Animals; Antineoplastic Agents; Aziridines; Cell Line, Tumor; Genetic Therapy; Genetic Vectors; HSP70 Heat-Shock Proteins; Immunotherapy; Male; Mice; Mice, Inbred C57BL; Necrosis; Nitroreductases; Prostatic Neoplasms; Proteomics

2006
Expression of Escherichia coli B nitroreductase in established human tumor xenografts in mice results in potent antitumoral and bystander effects upon systemic administration of the prodrug CB1954.
    Cancer gene therapy, 2000, Volume: 7, Issue:5

    Topics: Animals; Apoptosis; Aziridines; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Cross-Linking Reagents; Dose-Response Relationship, Drug; Escherichia coli; Head and Neck Neoplasms; Humans; Immunohistochemistry; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Necrosis; Neoplasm Transplantation; Neoplasms, Experimental; Nitroreductases; Prodrugs; Remission Induction; Time Factors; Tumor Cells, Cultured

2000